• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our BureauDeeptha Rajkumar

Rumours of a stake sale/takeover resurfaced at the counter of Matrix Laboratories driving prices up by more than 4 per cent on the BSE.

The company, which had sometime back considered taking over Stride Arcolab, is back on the market radar on takeover/acquisition talk.

According to market sources, the company has a good business model and as such is a prime target.

At these levels the stock is also considered fairly valued by analysts.

Dealers also said with several FIIs and a leading bull operator holding a large amount of shares of the company, any such talk would prop up the counter.

Among FIIs, Merrill Lynch Capital Markets Espana holds around 5.57 per cent shares of the company while Rakesh Jhunjhunwala has around 1.22 per cent share.

More Stories on : Stock Markets | Stocks | Pharmaceuticals | Ear to the ground

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Payment, settlement systems may come under RBI

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line